Description :
Renal denervation is a minimally invasive catheter-based procedure for the treatment of hypertension in patients . It is generally opted in cases where medicines fail to provide relief to the patient . In this procedure , nerves of the renal artery wall are ablated with the help of radiofrequency pulses or ultrasound . This leads to a reduction of sympathetic afferent and efferent kidney activity , which further leads to a reduction in blood pressure .
The world renal denervation market was $ 197 million in 2015 and is expected to reach $ 3,153 million by 2022 with a CAGR of 48.5 %. The market is driven by factors such as changes in lifestyle of the people , which leads to uncontrolled , treatment resistant hypertension , and ageing population . In addition to this , technological advancements have helped in the development of innovative and efficient denervation devices that have driven the market growth . However , low awareness for renal denervation procedure , stringent regulatory norms for renal denervation systems , and unfavorable reimbursements for renal denervation procedure have restricted the growth of the market .
Browse the full report @ http :// www . orbisresearch . com / reports / index / renal-denervationmarket-by-product-symplicity-enlightn-vessix-paradise-and-iberis-by-technology-radiofrequencyultrasound-and-micro-infusion-global-opportunity-analysis-and-industry-forecast-2014-2022 .
The report segments the market based on product , technology , and geography . Based on product , it is segmented into Symplicity Renal Denervation System , EnligHTN , Vessix Renal Denervation System , Paradise Renal Denervation System , and Iberis Renal Sympathetic Denervation System . Based on technology , the market is segmented into radiofrequency , ultrasound , and micro-infusion . Based on geography , the market is divided into four major regions , namely , North America ( the U . S ., Canada , and Mexico ), Europe ( Germany , France , U . K ., Italy , and Spain ), Asia-Pacific ( Japan , China , India , Australia , and New Zealand ), and LAMEA ( Brazil , South Africa , and Saudi Arabia ).
Check the DISCOUNT on this report @ http :// www . orbisresearch . com / contacts / discount / 222770 .
The market has witnessed product development and acquisitions in the recent years . These acquisitions have helped the major players to combine their forces with smaller players and enhance their business . In this regard , Boston Scientific Corporation acquired Vessix Vascular , Inc . ( November 2012 ) and Medtonic plc acquired Ardian , Inc . ( January 2011 ). Both Vessix Vascular , Inc . and Ardian , Inc . were the producers of renal denervation devices . However , due to smaller production capacities and limited geographical presence the systems were not popular in the market . However , after the acquisition these systems were produced on a large scale . This enabled Medtonic plc and Boston Scientific Corporation to emerge as the top leading companies for renal denervation devices .
Key players that operate in this market include Ablative Solutions , Inc ., Boston Scientific Corporation , Cardiosonic Ltd , Kona Medical , Inc ., Medtronic plc , Mercator MedSystems , Inc .,
2